Trademark PHELIX

This trademark (serial no. 86338600, mark text "PHELIX") was filed with USPTO on 2014-07-16 and has a current status of "fifth extension - granted". Use the tables below to research this trademark’s status, prosecution history events, classification of goods & services, and current owner, etc.

Basic Information

Actual Characters of Mark Text	PHELIX
Mark Physical Characteristics	Standard character mark
Trademark Current Status	Fifth extension - granted
Trademark Current Status Date	2017-07-07
Registration Number	0
Registration Date
Serial Number	86338600
Trademark Application Filing Date	2014-07-16
Date Mark Published for Opposition	2014-11-18

Illustration of trademark PHELIX

Mark Classification

1 Primary Classification Code 005

Mark First Use Anywhere:	N/A
Mark First Use in Commerce:	N/A
Class Status:	Active
Class Status Date:	2014-07-22
International Class:	1. Pharmaceuticals (5); 2. Medical Apparatus (10); 3. Medical services / Veterinary services / Hygienic and beauty care for humans or animals (44);
Prior U.S. Class:	1. Chemicals and Chemical Compositions (6);   2. Medicines and Pharmaceutical Preparations (18);   3. Dental, Medical, and Surgical Appliances (44);   4. Foods and Ingredients of Foods (46);   5. Cosmetics and Toilet Preparations (51);   6. Detergents and Soaps (52);   7. Measuring and Scientific Appliances (26);   8. Clothing (39);   9. Dental, Medical, and Surgical Appliances (44);   10. Miscellaneous (100);   11. Advertising and Business (101);
Classification Statement:	Pharmaceutical preparations for use in extracorporeal photopheresis, extracorporeal photo immune therapy, extracorporeal photo chemotherapy, cellular therapies, and the treatment of infectious diseases; pharmaceutical preparations and substances for use in immune therapy, the treatment of infectious diseases, the treatment of damaged skin and tissue, inflammation, blood disorders, and viral diseases and disorders

2 Primary Classification Code 010

Mark First Use Anywhere:	N/A
Mark First Use in Commerce:	N/A
Class Status:	Active
Class Status Date:	2014-07-22
International Class:	1. Pharmaceuticals (5); 2. Medical Apparatus (10); 3. Medical services / Veterinary services / Hygienic and beauty care for humans or animals (44);
Prior U.S. Class:	1. Chemicals and Chemical Compositions (6);   2. Medicines and Pharmaceutical Preparations (18);   3. Dental, Medical, and Surgical Appliances (44);   4. Foods and Ingredients of Foods (46);   5. Cosmetics and Toilet Preparations (51);   6. Detergents and Soaps (52);   7. Measuring and Scientific Appliances (26);   8. Clothing (39);   9. Dental, Medical, and Surgical Appliances (44);   10. Miscellaneous (100);   11. Advertising and Business (101);
Classification Statement:	Therapeutic medical devices for withdrawing blood from the body, separating the blood, treating the blood extracorporeally, and returning the blood to the body; therapeutic medical device used for extracorporeal photopheresis, extra corporeal photo immune therapy, extracorporeal photo chemotherapy, cellular therapies, and the treatment of infectious diseases

3 Primary Classification Code 044

Mark First Use Anywhere:	N/A
Mark First Use in Commerce:	N/A
Class Status:	Active
Class Status Date:	2014-07-22
International Class:	1. Pharmaceuticals (5); 2. Medical Apparatus (10); 3. Medical services / Veterinary services / Hygienic and beauty care for humans or animals (44);
Prior U.S. Class:	1. Chemicals and Chemical Compositions (6);   2. Medicines and Pharmaceutical Preparations (18);   3. Dental, Medical, and Surgical Appliances (44);   4. Foods and Ingredients of Foods (46);   5. Cosmetics and Toilet Preparations (51);   6. Detergents and Soaps (52);   7. Measuring and Scientific Appliances (26);   8. Clothing (39);   9. Dental, Medical, and Surgical Appliances (44);   10. Miscellaneous (100);   11. Advertising and Business (101);
Classification Statement:	Therapeutic medical treatment services relating to extracorporeal photopheresis, extra corporeal photo immune therapy, extracorporeal photo chemotherapy, cellular therapies, and the treatment of infectious diseases

Mark Owner Information

Owning Party Type:	Owner at Publication
Owner Name:	FRESENIUS KABI AG
Legal Entity Type:	Joint Stock Company
Address:	Else-Kröner-Str. 1, Bad Homburg 61352, , FED REP GERMANY

Owning Party Type:	Original Applicant
Owner Name:	FRESENIUS KABI AG
Legal Entity Type:	Joint Stock Company
Address:	Else-Kröner-Str. 1, Bad Homburg 61352, , FED REP GERMANY

Correspondent

Correspondent:	LEE J. EULGEN NEAL GERBER & EISENBERG LLP, 2 N LASALLE ST, CHICAGO, IL 60602
Attorney Name	Lee J. Eulgen
Attorney No.	20569.

Prosecution History Events

Event Date	Event Description
2017-06-23	TEAS EXTENSION RECEIVED
2017-01-05	NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2017-01-03	EXTENSION 4 GRANTED
2017-01-03	EXTENSION 4 FILED
2017-01-03	TEAS EXTENSION RECEIVED
2016-06-15	NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2016-06-14	EXTENSION 3 GRANTED
2016-05-06	EXTENSION 3 FILED
2016-06-12	CASE ASSIGNED TO INTENT TO USE PARALEGAL
2016-05-06	TEAS EXTENSION RECEIVED
2015-12-01	NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2015-11-28	EXTENSION 2 GRANTED
2015-11-11	EXTENSION 2 FILED
2015-11-28	CASE ASSIGNED TO INTENT TO USE PARALEGAL
2015-11-11	TEAS EXTENSION RECEIVED
2015-06-03	NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2015-06-01	EXTENSION 1 GRANTED
2015-06-01	EXTENSION 1 FILED
2015-06-01	TEAS EXTENSION RECEIVED
2015-01-13	NOA E-MAILED - SOU REQUIRED FROM APPLICANT
2014-11-18	OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2014-11-18	PUBLISHED FOR OPPOSITION
2014-10-29	NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2014-10-06	APPROVED FOR PUB - PRINCIPAL REGISTER
2014-10-06	ASSIGNED TO EXAMINER
2014-07-22	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2014-07-19	NEW APPLICATION ENTERED IN TRAM
2017-07-08	NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2017-07-07	EXTENSION 5 GRANTED
2017-06-23	EXTENSION 5 FILED
2017-07-06	CASE ASSIGNED TO INTENT TO USE PARALEGAL